ZOMACTON
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $2,380 | 133 | 113 |
| 2019 | $52,994 | 734 | 306 |
| 2018 | $17,726 | 905 | 425 |
| 2017 | $659,278 | 653 | 259 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $646,708 | 4 | 88.3% |
| Food and Beverage | $41,962 | 2,341 | 5.7% |
| Consulting Fee | $33,309 | 15 | 4.5% |
| Travel and Lodging | $10,399 | 65 | 1.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| An open-label, single-dose, randomized, 2-way cross-over study comparing pharmacokineticspharmacodynamics of 4 mg of ZOMACTONTM 5 mg powder and solvent for injection and 4 mg HUMATROPE 5 mg powder and solvent for injection administered subcutaneously in healthy adult subjects | Ferring International Pharmascience Center US | $646,708 | 0 |
Top Doctors Receiving Payments for ZOMACTON
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Hialeah, FL | $647,358 | 5 |
| , MD | Pediatric Endocrinology | Sacramento, CA | $5,272 | 28 |
| , MD | Pediatric Endocrinology | Los Angeles, CA | $5,190 | 14 |
| , MD | Pediatric Endocrinology | Cleveland, OH | $4,299 | 10 |
| , MD | Pediatric Endocrinology | Centennial, CO | $4,088 | 24 |
| , MD | Pediatric Endocrinology | Orlando, FL | $3,660 | 16 |
| , MD | Pediatric Endocrinology | Waltham, MA | $3,534 | 10 |
| , MD | Pediatric Endocrinology | Gainesville, FL | $3,465 | 8 |
| , M.D | Pediatric Endocrinology | Miami, FL | $3,449 | 17 |
| , M.D | Pediatric Endocrinology | Pittsburgh, PA | $3,280 | 13 |
| , M.D | Specialist | New York, NY | $3,273 | 4 |
| , MD | Pediatric Endocrinology | Morristown, NJ | $2,875 | 9 |
| , M.D | Pediatrics | Minneapolis, MN | $1,925 | 2 |
| , MD | Pediatric Endocrinology | Orlando, FL | $1,093 | 5 |
| , M.D | Pediatric Endocrinology | San Diego, CA | $833.11 | 36 |
| , M.D | Pediatric Endocrinology | San Diego, CA | $733.89 | 30 |
| , M.D | Pediatric Endocrinology | San Diego, CA | $715.95 | 30 |
| , M.D | Pediatrics | San Diego, CA | $685.55 | 29 |
| , MD | Pediatric Endocrinology | Los Angeles, CA | $591.07 | 25 |
| , M.D., PH.D | Pediatric Endocrinology | San Diego, CA | $590.28 | 24 |
| , M.D | Pediatrics | San Diego, CA | $575.54 | 24 |
| , MD | Emergency Medicine | Erie, PA | $521.01 | 22 |
| , M.D | Pediatric Endocrinology | San Diego, CA | $482.70 | 20 |
| Sarah Laurenzano | Pediatric Endocrinology | San Diego, CA | $442.53 | 17 |
| , M.D | Pediatric Endocrinology | San Antonio, TX | $438.55 | 32 |
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $732,378
- Total Doctors 673
- Transactions 2,425
About ZOMACTON
ZOMACTON is a drug associated with $732,378 in payments to 673 healthcare providers, recorded across 2,425 transactions in the CMS Open Payments database. The primary manufacturer is Ferring International Pharmascience Center US.
Payment data is available from 2017 to 2020. In 2020, $2,380 was paid across 133 transactions to 113 doctors.
The most common payment nature for ZOMACTON is "Unspecified" ($646,708, 88.3% of total).
ZOMACTON is associated with 1 research study, including "An open-label, single-dose, randomized, 2-way cross-over study comparing pharmacokineticspharmacodynamics of 4 mg of ZOMACTONTM 5 mg powder and solvent for injection and 4 mg HUMATROPE 5 mg powder and solvent for injection administered subcutaneously in healthy adult subjects" ($646,708).